Atyr Pharma Inc

ATYRNASDAQ · USD
3.82USD+3.69 (+3.53%)
332

Atyr Pharma Inc (ATYR) Option Chain

Read more

Tracking the ATYR option chain helps you see every strike and expiry on Atyr Pharma Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ATYR options activity at a glance. Use our scanner to monitor the ATYR option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ATYR stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ATYR options are being actively traded, and where they are not.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
98.131,39307.182.82—10.001.00+669.23—10.000.0010.008121.87
99.0300-2.222.32—0.101.50+1053.851.301.450.001.38410.97
99.41240-0.271.82—1.552.00+1438.46—20.000.0020.00540.59
99.73009.180.82—10.003.00+2207.69—20.000.0020.00010.27
99.853010.000.00—10.004.00+2976.923.804.500.183.97000.15

As of Nov 19, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank89.29% High
  • Market cap (M$)13
  • 52 weeks high-99.71%
  • 52 weeks low-96.81%
  • Analyst recommendationBuy
    2.14
  • Target price$3.20
    -16.23% below the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-05
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.62
  • EPS growth next 5 years22.90%

As of Nov 19, 2026